In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin

ABSTRACT: Background Oxacillin continues to be an important agent in the treatment of staphylococcal infections; many generic products are available and the only requirement for their approval is demonstration of pharmaceutical equivalence. We tested the assumption that pharmaceutical equivalence pr...